Assessing Type 2 Diabetes Mellitus Risk: A Screening Approach for Overweight and Obesity Using the CANRISK Questionnaire
Research in Clinical Pharmacy · 2024
DOI: 10.59931/rcp.24.0008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research in Clinical Pharmacy, 2024. Verfasst von Elida Zairina und 3 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Faculty of Pharmacy, Universitas Airlangga, Lembaga Penelitian dan Pengabdian Masyarakat (LPPM) Universitas Airlangga.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
This study aimed to evaluate the risk of developing type 2 diabetes mellitus (T2DM) among individuals with a body mass index (BMI) higher than the normal range.
Methods
This cross-sectional study used a convenience sampling technique.Data were collected using the Canadian Diabetes Risk (CANRISK) questionnaire.
Results
Among 121 respondents, 76 (62.8%) had a high-risk factor, 11 (9.1%) had a lowrisk factor, and 34 (28.1%) had a medium-risk factor for developing T2DM within the next ten years.Differential analysis indicated significant associations between CANRISK total scores and age (p=0.001),gender (p=0.006), and education level (p=0.002).However, no significant differences were observed based on physical activity, fruit and vegetable consumption, history of high blood glucose, or family history of diabetes.
Conclusion
Individuals with higher CANRISK scores have an increased likelihood of developing T2DM within ten years.The CANRISK questionnaire is an effective screening tool for identifying at-risk individuals, particularly those with elevated BMI.
Förderung
- Faculty of Pharmacy, Universitas Airlangga
- Lembaga Penelitian dan Pengabdian Masyarakat (LPPM) Universitas Airlangga
Zitieren
APA
Zairina, E., Girath, Y. E., Sulistyarini, A., & Nugraheni, G. (2024). Assessing Type 2 Diabetes Mellitus Risk: A Screening Approach for Overweight and Obesity Using the CANRISK Questionnaire. Research in Clinical Pharmacy. https://doi.org/10.59931/rcp.24.0008
Vancouver
Zairina E, Girath YE, Sulistyarini A, Nugraheni G. Assessing Type 2 Diabetes Mellitus Risk: A Screening Approach for Overweight and Obesity Using the CANRISK Questionnaire. Research in Clinical Pharmacy. 2024. doi:10.59931/rcp.24.0008
BibTeX
@article{Zairina2024,
author = {Zairina, Elida and Girath, Yerlita El and Sulistyarini, Arie and Nugraheni, Gesnita},
title = {Assessing Type 2 Diabetes Mellitus Risk: A Screening Approach for Overweight and Obesity Using the CANRISK Questionnaire},
journal = {Research in Clinical Pharmacy},
year = {2024},
doi = {10.59931/rcp.24.0008}
}
EUVIMED